Results 141 to 150 of about 8,824 (191)

Maribavir for the Management of a Complex Cytomegalovirus (CMV) Infection After Liver Transplantation: Refractoriness and Intolerance to Standard Therapies in the Intensive Care Unit. [PDF]

Cureus
Santos L, Inácio H, Cochicho Ramalho A, Rodeia SC, Germano N.   +4 more
europepmc   +1 more source

Acyclovir-Resistant Herpes Simplex Virus in Pediatric Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant: A Case Series. [PDF]

Transpl Infect Dis
Nunn J, Ahmed A, Senthil S, Mirci-Danicar O, Bonney D, Horgan C, Mustafa O, Wynn R, Guiver M, Nataraj R.   +9 more
europepmc   +1 more source

Anti-Infective-Associated AKI: A Narrative Review of the Epidemiology, Mechanisms, Risk Factors, Biomarkers, Clinical Course, Monitoring, Prevention, and Therapeutic Strategies. [PDF]

Antibiotics (Basel)
Karimzadeh I, Kane-Gill SL, Ma B.
europepmc   +1 more source

Frequency and Characterization of Local Ocular Toxicity in Cats Treated With Topical Ophthalmic Cidofovir for Presumptive Feline Herpesvirus-1 Infection. [PDF]

Vet Ophthalmol
Ledbetter EC, Morgan AJ.
europepmc   +1 more source

Anal High-Grade Squamous Intraepithelial Lesions in People Living with HIV: A Systematic Review of Treatment Outcomes. [PDF]

Cancers (Basel)
Dapper H, Aigner F, Stephan C, Rudroff C, Martin D, Rödel F, Minsky B, Ludmir EB, Messick C, Kitchens C, Romesser PB, Garcia-Aguilar J, Smith JJ, Rödel C, Wieland U, Bopp L, Fokas E.   +16 more
europepmc   +1 more source

Monkeypox Infection in Kidney Transplant Recipients.

Kidney Blood Press Res
Sheng AQ, Zhao ZQ, Liu F, Wang JJ, Mao JH, Fu HD.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Cidofovir

Drugs, 1996
Cidofovir is a nucleotide analogue which inhibits viral DNA polymerase and is effective against human cytomegalovirus (CMV) infection. It is phosphorylated to its active form by cellular enzymes. With the long intracellular half-life of its metabolites, cidofovir can be administered weekly during induction and every other week during maintenance ...
A P, Lea, H M, Bryson
  +5 more sources

Side-effects of cidofovir in the treatment of recurrent respiratory papillomatosis

European Archives of Oto-Rhino-Laryngology, 2008
Recurrent respiratory papillomatosis (RRP) is a chronic and difficult to treat disease of the larynx. In 1998, the first article was published that described the use of the antiviral substance cidofovir to treat this disease.
Frederik G Dikkers, Ferdinand I Broekema
exaly   +2 more sources

Intralesional Cidofovir Therapy for Laryngeal Papilloma in an Adult Cohort

Laryngoscope, 2002
Objectives: To confirm the safety and efficacy of intralesional cidofovir in the management of laryngeal papilloma and to identify variables that correlate with number of injections needed to achieve remission.
Sheila Stager, Steven Bielamowicz, William R Wilson   +2 more
exaly   +2 more sources